Delivery Order SPE2DB22D2206-SPE2DB24FGN15
Award Date 4/5/24
Potential Completion Date 4/8/24
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Cyclosporine 0.05% eye emulsion in 30-count packages. The $1,107.10 contract has a completion date of February 20, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,954.08 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Cyclosporine 0.05% Eye Emulsion, with a performance period through May 1, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The $2,181.63 contract has an ultimate completion date of December 5, 2022 and is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceuticals and medical supplies to support military...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Cyclosporine 0.05% eye emulsion medication. The contract has a potential value of $1,954.08 and a performance period through February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for CYCLOSPORINE 0.05% EYE EMULS 60S. The delivery order has a potential value of $7,335.36 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a supplier of pharmaceuticals and medical supplies to U.S. government agencies, particularly the Department of Defense. The contract does...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $8,357.70 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of Cyclosporine 0.05% Eye Emulsion, a specialty pharmaceutical product. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order for $2,092.92 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Cyclosporine 0.05% eye emulsion. This award has a completion date of March 6, 2024 and is not set aside. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver pharmaceutical...
- This federal contract award is for $7,424.52 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA). The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999, which serves as a primary vehicle for supplying a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. This...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The contract is a firm-fixed-price delivery order worth $2,969.72, with a period of performance through September 27, 2024. AmerisourceBergen is the prime contractor and there is no set-aside designation mentioned. This order is likely part of a larger Indefinite Delivery Contract (IDC) between...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion in 60-count packages to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,008.44 and is a firm fixed-price delivery order with a completion date of December 6, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization registered in...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGN15Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Cyclosporine 0.05% eye emulsion in 30-count packages. The $1,846.14 contract has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a separate $999,999,999.00 indefinite delivery contract with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. This contract does not have a set-aside designation.
Generated 7/5/24, 9:23 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 4/5/24 |